FibroFind
FibroFind uses intact, viable precision-cut human tissue cultured with proprietary bioreactor technology to provide biopharmaceutical companies with decision-grade, high-fidelity evidence, ensuring that only the most promising treatments reach patients. We advance high-potential treatments from target identification and validation through lead optimization, pharmacology and toxicology studies. FibroFind’s unique platform therefore bridges the translational gap between preclinical prediction and clinical reality.
